ChromaDex Research & Development Facility Earns ISO/IEC 17025:2017 Accreditation

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC) announced today it has achieved ISO/IEC 17025:2017 quality standard for laboratory testing, the world’s most respected quality management standard. This accreditation covers testing of the Company’s Tru Niagen® consumer products, its Niagen® ingredient, and phytochemical reference standards performed out of its quality control and R&D facility in Longmont, Colorado. The accreditation requires demonstration of full and continuous co

Click to view original post